Literature DB >> 32725207

COVID-19 and Hypercoagulability: Potential Impact on Management with Oral Contraceptives, Estrogen Therapy and Pregnancy.

Daniel I Spratt1, Rachel J Buchsbaum2.   

Abstract

Entities:  

Keywords:  COVID-19; coronavirus; estrogen therapy; hypercoagulability; oral contraceptives; pregnancy

Mesh：

Substances：

Year:  2020        PMID： 32725207      PMCID： PMC7454527          DOI： 10.1210/endocr/bqaa121

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  3 in total

1.  Acute pulmonary embolism in a patient with mild COVID-19 symptoms: a case report.

Authors:  Norberto B Fiorini; Fernando Garagoli; Rosana C Bustamante; Rodolfo Pizarro
Journal:  Eur Heart J Case Rep       Date:  2021-01-21

Review 2.  The immune response to COVID-19: Does sex matter?

Authors:  Jim Q Ho; Mohammad Reza Sepand; Banafsheh Bigdelou; Tala Shekarian; Rahim Esfandyarpour; Prashant Chauhan; Vahid Serpooshan; Lalit K Beura; Gregor Hutter; Steven Zanganeh
Journal:  Immunology       Date:  2022-05-03       Impact factor: 7.215

3.  Hormonal therapies and venous thrombosis: Considerations for prevention and management.

Authors:  Corinne LaVasseur; Suvi Neukam; Thomas Kartika; Bethany Samuelson Bannow; Joseph Shatzel; Thomas G DeLoughery
Journal:  Res Pract Thromb Haemost       Date:  2022-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.